Global Oncolytic Virus Therapies Market Research Report 2026(Status and Outlook)
Oncolytic Virus Therapies are a form of biological treatment using genetically modified viruses to selectively infect and destroy cancer cells. By replicating within tumor cells, the viruses induce cell lysis while stimulating the immune system to combat cancer. The technology focuses on viral targeting and safety optimization, offering clinical potential for specific tumor types and advancing the field of cancer immunotherapy.
The global Oncolytic Virus Therapies market size was estimated at USD 265.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Virus Therapies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Virus Therapies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Virus Therapies market.
Global Oncolytic Virus Therapies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AMGEN
Shanghai Sunway Biotech
Daiichi Sankyo
Calidi Biotherapeutics
Replimune
Sibiono
Binhui Biopharm
Tasly
Sinopharm
Biottt
Sinorda
Market Segmentation (by Type)
Naturally Occurring Oncolytic Virus Therapies
Genetically Modified Oncolytic Virus Therapies
Market Segmentation (by Application)
Solid Tumors
Non-Solid Tumors
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncolytic Virus Therapies Market
Overview of the regional outlook of the Oncolytic Virus Therapies Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Therapies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oncolytic Virus Therapies market size was estimated at USD 265.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Virus Therapies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Virus Therapies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Virus Therapies market.
Global Oncolytic Virus Therapies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AMGEN
Shanghai Sunway Biotech
Daiichi Sankyo
Calidi Biotherapeutics
Replimune
Sibiono
Binhui Biopharm
Tasly
Sinopharm
Biottt
Sinorda
Market Segmentation (by Type)
Naturally Occurring Oncolytic Virus Therapies
Genetically Modified Oncolytic Virus Therapies
Market Segmentation (by Application)
Solid Tumors
Non-Solid Tumors
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncolytic Virus Therapies Market
Overview of the regional outlook of the Oncolytic Virus Therapies Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Virus Therapies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncolytic Virus Therapies
1.2 Key Market Segments
1.2.1 Oncolytic Virus Therapies Segment by Type
1.2.2 Oncolytic Virus Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Therapies Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Virus Therapies Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Virus Therapies Product Life Cycle
3.3 Global Oncolytic Virus Therapies Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Virus Therapies Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Virus Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Virus Therapies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Virus Therapies Market Competitive Situation and Trends
3.8.1 Oncolytic Virus Therapies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Virus Therapies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Virus Therapies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Virus Therapies Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC VIRUS THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Therapies Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Virus Therapies Market Size by Type (2020-2025)
6.4 Global Oncolytic Virus Therapies Price by Type (2020-2025)
7 ONCOLYTIC VIRUS THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Therapies Market Sales by Application (2020-2025)
7.3 Global Oncolytic Virus Therapies Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC VIRUS THERAPIES MARKET SALES BY REGION
8.1 Global Oncolytic Virus Therapies Sales by Region
8.1.1 Global Oncolytic Virus Therapies Sales by Region
8.1.2 Global Oncolytic Virus Therapies Sales Market Share by Region
8.2 Global Oncolytic Virus Therapies Market Size by Region
8.2.1 Global Oncolytic Virus Therapies Market Size by Region
8.2.2 Global Oncolytic Virus Therapies Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Virus Therapies Sales by Country
8.3.2 North America Oncolytic Virus Therapies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Virus Therapies Sales by Country
8.4.2 Europe Oncolytic Virus Therapies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Virus Therapies Sales by Region
8.5.2 Asia Pacific Oncolytic Virus Therapies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Virus Therapies Sales by Country
8.6.2 South America Oncolytic Virus Therapies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Virus Therapies Sales by Region
8.7.2 Middle East and Africa Oncolytic Virus Therapies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC VIRUS THERAPIES MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Therapies by Region(2020-2025)
9.2 Global Oncolytic Virus Therapies Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Virus Therapies Production
9.4.1 North America Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Virus Therapies Production
9.5.1 Europe Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Virus Therapies Production (2020-2025)
9.6.1 Japan Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Virus Therapies Production (2020-2025)
9.7.1 China Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AMGEN
10.1.1 AMGEN Basic Information
10.1.2 AMGEN Oncolytic Virus Therapies Product Overview
10.1.3 AMGEN Oncolytic Virus Therapies Product Market Performance
10.1.4 AMGEN Business Overview
10.1.5 AMGEN SWOT Analysis
10.1.6 AMGEN Recent Developments
10.2 Shanghai Sunway Biotech
10.2.1 Shanghai Sunway Biotech Basic Information
10.2.2 Shanghai Sunway Biotech Oncolytic Virus Therapies Product Overview
10.2.3 Shanghai Sunway Biotech Oncolytic Virus Therapies Product Market Performance
10.2.4 Shanghai Sunway Biotech Business Overview
10.2.5 Shanghai Sunway Biotech SWOT Analysis
10.2.6 Shanghai Sunway Biotech Recent Developments
10.3 Daiichi Sankyo
10.3.1 Daiichi Sankyo Basic Information
10.3.2 Daiichi Sankyo Oncolytic Virus Therapies Product Overview
10.3.3 Daiichi Sankyo Oncolytic Virus Therapies Product Market Performance
10.3.4 Daiichi Sankyo Business Overview
10.3.5 Daiichi Sankyo SWOT Analysis
10.3.6 Daiichi Sankyo Recent Developments
10.4 Calidi Biotherapeutics
10.4.1 Calidi Biotherapeutics Basic Information
10.4.2 Calidi Biotherapeutics Oncolytic Virus Therapies Product Overview
10.4.3 Calidi Biotherapeutics Oncolytic Virus Therapies Product Market Performance
10.4.4 Calidi Biotherapeutics Business Overview
10.4.5 Calidi Biotherapeutics Recent Developments
10.5 Replimune
10.5.1 Replimune Basic Information
10.5.2 Replimune Oncolytic Virus Therapies Product Overview
10.5.3 Replimune Oncolytic Virus Therapies Product Market Performance
10.5.4 Replimune Business Overview
10.5.5 Replimune Recent Developments
10.6 Sibiono
10.6.1 Sibiono Basic Information
10.6.2 Sibiono Oncolytic Virus Therapies Product Overview
10.6.3 Sibiono Oncolytic Virus Therapies Product Market Performance
10.6.4 Sibiono Business Overview
10.6.5 Sibiono Recent Developments
10.7 Binhui Biopharm
10.7.1 Binhui Biopharm Basic Information
10.7.2 Binhui Biopharm Oncolytic Virus Therapies Product Overview
10.7.3 Binhui Biopharm Oncolytic Virus Therapies Product Market Performance
10.7.4 Binhui Biopharm Business Overview
10.7.5 Binhui Biopharm Recent Developments
10.8 Tasly
10.8.1 Tasly Basic Information
10.8.2 Tasly Oncolytic Virus Therapies Product Overview
10.8.3 Tasly Oncolytic Virus Therapies Product Market Performance
10.8.4 Tasly Business Overview
10.8.5 Tasly Recent Developments
10.9 Sinopharm
10.9.1 Sinopharm Basic Information
10.9.2 Sinopharm Oncolytic Virus Therapies Product Overview
10.9.3 Sinopharm Oncolytic Virus Therapies Product Market Performance
10.9.4 Sinopharm Business Overview
10.9.5 Sinopharm Recent Developments
10.10 Biottt
10.10.1 Biottt Basic Information
10.10.2 Biottt Oncolytic Virus Therapies Product Overview
10.10.3 Biottt Oncolytic Virus Therapies Product Market Performance
10.10.4 Biottt Business Overview
10.10.5 Biottt Recent Developments
10.11 Sinorda
10.11.1 Sinorda Basic Information
10.11.2 Sinorda Oncolytic Virus Therapies Product Overview
10.11.3 Sinorda Oncolytic Virus Therapies Product Market Performance
10.11.4 Sinorda Business Overview
10.11.5 Sinorda Recent Developments
11 ONCOLYTIC VIRUS THERAPIES MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Therapies Market Size Forecast
11.2 Global Oncolytic Virus Therapies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Therapies Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Therapies Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Therapies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Virus Therapies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Virus Therapies Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Virus Therapies by Type (2026-2035)
12.1.2 Global Oncolytic Virus Therapies Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Virus Therapies by Type (2026-2035)
12.2 Global Oncolytic Virus Therapies Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Virus Therapies Sales (K MT) Forecast by Application
12.2.2 Global Oncolytic Virus Therapies Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncolytic Virus Therapies
1.2 Key Market Segments
1.2.1 Oncolytic Virus Therapies Segment by Type
1.2.2 Oncolytic Virus Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Therapies Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Virus Therapies Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Virus Therapies Product Life Cycle
3.3 Global Oncolytic Virus Therapies Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Virus Therapies Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Virus Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Virus Therapies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Virus Therapies Market Competitive Situation and Trends
3.8.1 Oncolytic Virus Therapies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Virus Therapies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Virus Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Virus Therapies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Virus Therapies Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC VIRUS THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Therapies Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Virus Therapies Market Size by Type (2020-2025)
6.4 Global Oncolytic Virus Therapies Price by Type (2020-2025)
7 ONCOLYTIC VIRUS THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Therapies Market Sales by Application (2020-2025)
7.3 Global Oncolytic Virus Therapies Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC VIRUS THERAPIES MARKET SALES BY REGION
8.1 Global Oncolytic Virus Therapies Sales by Region
8.1.1 Global Oncolytic Virus Therapies Sales by Region
8.1.2 Global Oncolytic Virus Therapies Sales Market Share by Region
8.2 Global Oncolytic Virus Therapies Market Size by Region
8.2.1 Global Oncolytic Virus Therapies Market Size by Region
8.2.2 Global Oncolytic Virus Therapies Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Virus Therapies Sales by Country
8.3.2 North America Oncolytic Virus Therapies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Virus Therapies Sales by Country
8.4.2 Europe Oncolytic Virus Therapies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Virus Therapies Sales by Region
8.5.2 Asia Pacific Oncolytic Virus Therapies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Virus Therapies Sales by Country
8.6.2 South America Oncolytic Virus Therapies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Virus Therapies Sales by Region
8.7.2 Middle East and Africa Oncolytic Virus Therapies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC VIRUS THERAPIES MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Virus Therapies by Region(2020-2025)
9.2 Global Oncolytic Virus Therapies Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Virus Therapies Production
9.4.1 North America Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Virus Therapies Production
9.5.1 Europe Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Virus Therapies Production (2020-2025)
9.6.1 Japan Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Virus Therapies Production (2020-2025)
9.7.1 China Oncolytic Virus Therapies Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Virus Therapies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AMGEN
10.1.1 AMGEN Basic Information
10.1.2 AMGEN Oncolytic Virus Therapies Product Overview
10.1.3 AMGEN Oncolytic Virus Therapies Product Market Performance
10.1.4 AMGEN Business Overview
10.1.5 AMGEN SWOT Analysis
10.1.6 AMGEN Recent Developments
10.2 Shanghai Sunway Biotech
10.2.1 Shanghai Sunway Biotech Basic Information
10.2.2 Shanghai Sunway Biotech Oncolytic Virus Therapies Product Overview
10.2.3 Shanghai Sunway Biotech Oncolytic Virus Therapies Product Market Performance
10.2.4 Shanghai Sunway Biotech Business Overview
10.2.5 Shanghai Sunway Biotech SWOT Analysis
10.2.6 Shanghai Sunway Biotech Recent Developments
10.3 Daiichi Sankyo
10.3.1 Daiichi Sankyo Basic Information
10.3.2 Daiichi Sankyo Oncolytic Virus Therapies Product Overview
10.3.3 Daiichi Sankyo Oncolytic Virus Therapies Product Market Performance
10.3.4 Daiichi Sankyo Business Overview
10.3.5 Daiichi Sankyo SWOT Analysis
10.3.6 Daiichi Sankyo Recent Developments
10.4 Calidi Biotherapeutics
10.4.1 Calidi Biotherapeutics Basic Information
10.4.2 Calidi Biotherapeutics Oncolytic Virus Therapies Product Overview
10.4.3 Calidi Biotherapeutics Oncolytic Virus Therapies Product Market Performance
10.4.4 Calidi Biotherapeutics Business Overview
10.4.5 Calidi Biotherapeutics Recent Developments
10.5 Replimune
10.5.1 Replimune Basic Information
10.5.2 Replimune Oncolytic Virus Therapies Product Overview
10.5.3 Replimune Oncolytic Virus Therapies Product Market Performance
10.5.4 Replimune Business Overview
10.5.5 Replimune Recent Developments
10.6 Sibiono
10.6.1 Sibiono Basic Information
10.6.2 Sibiono Oncolytic Virus Therapies Product Overview
10.6.3 Sibiono Oncolytic Virus Therapies Product Market Performance
10.6.4 Sibiono Business Overview
10.6.5 Sibiono Recent Developments
10.7 Binhui Biopharm
10.7.1 Binhui Biopharm Basic Information
10.7.2 Binhui Biopharm Oncolytic Virus Therapies Product Overview
10.7.3 Binhui Biopharm Oncolytic Virus Therapies Product Market Performance
10.7.4 Binhui Biopharm Business Overview
10.7.5 Binhui Biopharm Recent Developments
10.8 Tasly
10.8.1 Tasly Basic Information
10.8.2 Tasly Oncolytic Virus Therapies Product Overview
10.8.3 Tasly Oncolytic Virus Therapies Product Market Performance
10.8.4 Tasly Business Overview
10.8.5 Tasly Recent Developments
10.9 Sinopharm
10.9.1 Sinopharm Basic Information
10.9.2 Sinopharm Oncolytic Virus Therapies Product Overview
10.9.3 Sinopharm Oncolytic Virus Therapies Product Market Performance
10.9.4 Sinopharm Business Overview
10.9.5 Sinopharm Recent Developments
10.10 Biottt
10.10.1 Biottt Basic Information
10.10.2 Biottt Oncolytic Virus Therapies Product Overview
10.10.3 Biottt Oncolytic Virus Therapies Product Market Performance
10.10.4 Biottt Business Overview
10.10.5 Biottt Recent Developments
10.11 Sinorda
10.11.1 Sinorda Basic Information
10.11.2 Sinorda Oncolytic Virus Therapies Product Overview
10.11.3 Sinorda Oncolytic Virus Therapies Product Market Performance
10.11.4 Sinorda Business Overview
10.11.5 Sinorda Recent Developments
11 ONCOLYTIC VIRUS THERAPIES MARKET FORECAST BY REGION
11.1 Global Oncolytic Virus Therapies Market Size Forecast
11.2 Global Oncolytic Virus Therapies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Virus Therapies Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Virus Therapies Market Size Forecast by Region
11.2.4 South America Oncolytic Virus Therapies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Virus Therapies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Virus Therapies Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Virus Therapies by Type (2026-2035)
12.1.2 Global Oncolytic Virus Therapies Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Virus Therapies by Type (2026-2035)
12.2 Global Oncolytic Virus Therapies Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Virus Therapies Sales (K MT) Forecast by Application
12.2.2 Global Oncolytic Virus Therapies Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Virus Therapies Market Size by Type (M USD)
Table 4. Global Oncolytic Virus Therapies Market Size by Application
Table 5. Oncolytic Virus Therapies Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Virus Therapies Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Virus Therapies Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Virus Therapies Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Virus Therapies Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapies as of 2025)
Table 11. Global Market Oncolytic Virus Therapies Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Virus Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Therapies Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Virus Therapies Sales by Type (K MT)
Table 27. Global Oncolytic Virus Therapies Market Size by Type (M USD)
Table 28. Global Oncolytic Virus Therapies Sales (K MT) by Type (2020-2025)
Table 29. Global Oncolytic Virus Therapies Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Virus Therapies Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Virus Therapies Market Share by Type (2020-2025)
Table 32. Global Oncolytic Virus Therapies Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncolytic Virus Therapies Sales (K MT) by Application
Table 34. Global Oncolytic Virus Therapies Market Size by Application
Table 35. Global Oncolytic Virus Therapies Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncolytic Virus Therapies Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Virus Therapies Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Virus Therapies Market Share by Application (2020-2025)
Table 39. Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncolytic Virus Therapies Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Virus Therapies Market Size by Region (2020-2025)
Table 44. North America Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Virus Therapies Production (K MT) by Region(2020-2025)
Table 55. Global Oncolytic Virus Therapies Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Virus Therapies Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AMGEN Basic Information
Table 63. AMGEN Oncolytic Virus Therapies Product Overview
Table 64. AMGEN Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AMGEN Business Overview
Table 66. AMGEN SWOT Analysis
Table 67. AMGEN Recent Developments
Table 68. Shanghai Sunway Biotech Basic Information
Table 69. Shanghai Sunway Biotech Oncolytic Virus Therapies Product Overview
Table 70. Shanghai Sunway Biotech Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Shanghai Sunway Biotech Business Overview
Table 72. Shanghai Sunway Biotech SWOT Analysis
Table 73. Shanghai Sunway Biotech Recent Developments
Table 74. Daiichi Sankyo Basic Information
Table 75. Daiichi Sankyo Oncolytic Virus Therapies Product Overview
Table 76. Daiichi Sankyo Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo SWOT Analysis
Table 79. Daiichi Sankyo Recent Developments
Table 80. Calidi Biotherapeutics Basic Information
Table 81. Calidi Biotherapeutics Oncolytic Virus Therapies Product Overview
Table 82. Calidi Biotherapeutics Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Calidi Biotherapeutics Business Overview
Table 84. Calidi Biotherapeutics Recent Developments
Table 85. Replimune Basic Information
Table 86. Replimune Oncolytic Virus Therapies Product Overview
Table 87. Replimune Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Replimune Business Overview
Table 89. Replimune Recent Developments
Table 90. Sibiono Basic Information
Table 91. Sibiono Oncolytic Virus Therapies Product Overview
Table 92. Sibiono Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sibiono Business Overview
Table 94. Sibiono Recent Developments
Table 95. Binhui Biopharm Basic Information
Table 96. Binhui Biopharm Oncolytic Virus Therapies Product Overview
Table 97. Binhui Biopharm Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Binhui Biopharm Business Overview
Table 99. Binhui Biopharm Recent Developments
Table 100. Tasly Basic Information
Table 101. Tasly Oncolytic Virus Therapies Product Overview
Table 102. Tasly Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Tasly Business Overview
Table 104. Tasly Recent Developments
Table 105. Sinopharm Basic Information
Table 106. Sinopharm Oncolytic Virus Therapies Product Overview
Table 107. Sinopharm Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sinopharm Business Overview
Table 109. Sinopharm Recent Developments
Table 110. Biottt Basic Information
Table 111. Biottt Oncolytic Virus Therapies Product Overview
Table 112. Biottt Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Biottt Business Overview
Table 114. Biottt Recent Developments
Table 115. Sinorda Basic Information
Table 116. Sinorda Oncolytic Virus Therapies Product Overview
Table 117. Sinorda Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sinorda Business Overview
Table 119. Sinorda Recent Developments
Table 120. Global Oncolytic Virus Therapies Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Oncolytic Virus Therapies Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Oncolytic Virus Therapies Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Oncolytic Virus Therapies Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Oncolytic Virus Therapies Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Oncolytic Virus Therapies Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Oncolytic Virus Therapies Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Oncolytic Virus Therapies Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Oncolytic Virus Therapies Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Virus Therapies Market Size by Type (M USD)
Table 4. Global Oncolytic Virus Therapies Market Size by Application
Table 5. Oncolytic Virus Therapies Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Virus Therapies Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Virus Therapies Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Virus Therapies Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Virus Therapies Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapies as of 2025)
Table 11. Global Market Oncolytic Virus Therapies Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Virus Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Therapies Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Virus Therapies Sales by Type (K MT)
Table 27. Global Oncolytic Virus Therapies Market Size by Type (M USD)
Table 28. Global Oncolytic Virus Therapies Sales (K MT) by Type (2020-2025)
Table 29. Global Oncolytic Virus Therapies Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Virus Therapies Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Virus Therapies Market Share by Type (2020-2025)
Table 32. Global Oncolytic Virus Therapies Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncolytic Virus Therapies Sales (K MT) by Application
Table 34. Global Oncolytic Virus Therapies Market Size by Application
Table 35. Global Oncolytic Virus Therapies Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncolytic Virus Therapies Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Virus Therapies Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Virus Therapies Market Share by Application (2020-2025)
Table 39. Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncolytic Virus Therapies Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Virus Therapies Market Size by Region (2020-2025)
Table 44. North America Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Virus Therapies Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncolytic Virus Therapies Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Virus Therapies Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncolytic Virus Therapies Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Virus Therapies Production (K MT) by Region(2020-2025)
Table 55. Global Oncolytic Virus Therapies Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Virus Therapies Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncolytic Virus Therapies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. AMGEN Basic Information
Table 63. AMGEN Oncolytic Virus Therapies Product Overview
Table 64. AMGEN Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. AMGEN Business Overview
Table 66. AMGEN SWOT Analysis
Table 67. AMGEN Recent Developments
Table 68. Shanghai Sunway Biotech Basic Information
Table 69. Shanghai Sunway Biotech Oncolytic Virus Therapies Product Overview
Table 70. Shanghai Sunway Biotech Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Shanghai Sunway Biotech Business Overview
Table 72. Shanghai Sunway Biotech SWOT Analysis
Table 73. Shanghai Sunway Biotech Recent Developments
Table 74. Daiichi Sankyo Basic Information
Table 75. Daiichi Sankyo Oncolytic Virus Therapies Product Overview
Table 76. Daiichi Sankyo Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo SWOT Analysis
Table 79. Daiichi Sankyo Recent Developments
Table 80. Calidi Biotherapeutics Basic Information
Table 81. Calidi Biotherapeutics Oncolytic Virus Therapies Product Overview
Table 82. Calidi Biotherapeutics Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Calidi Biotherapeutics Business Overview
Table 84. Calidi Biotherapeutics Recent Developments
Table 85. Replimune Basic Information
Table 86. Replimune Oncolytic Virus Therapies Product Overview
Table 87. Replimune Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Replimune Business Overview
Table 89. Replimune Recent Developments
Table 90. Sibiono Basic Information
Table 91. Sibiono Oncolytic Virus Therapies Product Overview
Table 92. Sibiono Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sibiono Business Overview
Table 94. Sibiono Recent Developments
Table 95. Binhui Biopharm Basic Information
Table 96. Binhui Biopharm Oncolytic Virus Therapies Product Overview
Table 97. Binhui Biopharm Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Binhui Biopharm Business Overview
Table 99. Binhui Biopharm Recent Developments
Table 100. Tasly Basic Information
Table 101. Tasly Oncolytic Virus Therapies Product Overview
Table 102. Tasly Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Tasly Business Overview
Table 104. Tasly Recent Developments
Table 105. Sinopharm Basic Information
Table 106. Sinopharm Oncolytic Virus Therapies Product Overview
Table 107. Sinopharm Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sinopharm Business Overview
Table 109. Sinopharm Recent Developments
Table 110. Biottt Basic Information
Table 111. Biottt Oncolytic Virus Therapies Product Overview
Table 112. Biottt Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Biottt Business Overview
Table 114. Biottt Recent Developments
Table 115. Sinorda Basic Information
Table 116. Sinorda Oncolytic Virus Therapies Product Overview
Table 117. Sinorda Oncolytic Virus Therapies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sinorda Business Overview
Table 119. Sinorda Recent Developments
Table 120. Global Oncolytic Virus Therapies Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Oncolytic Virus Therapies Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Oncolytic Virus Therapies Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Oncolytic Virus Therapies Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Oncolytic Virus Therapies Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Oncolytic Virus Therapies Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Oncolytic Virus Therapies Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Oncolytic Virus Therapies Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Oncolytic Virus Therapies Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Oncolytic Virus Therapies Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Oncolytic Virus Therapies Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncolytic Virus Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Therapies Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Virus Therapies Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Virus Therapies Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Therapies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Virus Therapies Product Life Cycle
Figure 13. Oncolytic Virus Therapies Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Virus Therapies Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Virus Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Virus Therapies Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Therapies Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Virus Therapies
Figure 19. Global Oncolytic Virus Therapies Market PEST Analysis
Figure 20. Global Oncolytic Virus Therapies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Virus Therapies Market Share by Type
Figure 27. Sales Market Share of Oncolytic Virus Therapies by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Virus Therapies by Type in 2025
Figure 29. Market Share of Oncolytic Virus Therapies by Type (2020-2025)
Figure 30. Market Share of Oncolytic Virus Therapies by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Virus Therapies Market Share by Application
Figure 33. Global Oncolytic Virus Therapies Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Virus Therapies Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Virus Therapies Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Virus Therapies Market Share by Application in 2025
Figure 37. Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Virus Therapies Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Virus Therapies Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Virus Therapies Market Size by Country in 2024
Figure 45. U.S. Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Virus Therapies Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Virus Therapies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Virus Therapies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Virus Therapies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Virus Therapies Market Size by Country in 2024
Figure 55. Germany Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncolytic Virus Therapies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Virus Therapies Market Size by Region in 2024
Figure 68. China Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 79. South America Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Virus Therapies Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Virus Therapies Market Size by Country in 2024
Figure 82. Brazil Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncolytic Virus Therapies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Virus Therapies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Virus Therapies Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Virus Therapies Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Virus Therapies Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncolytic Virus Therapies Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Virus Therapies Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Virus Therapies Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Virus Therapies Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Virus Therapies Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oncolytic Virus Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Therapies Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Virus Therapies Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Virus Therapies Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Virus Therapies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Virus Therapies Product Life Cycle
Figure 13. Oncolytic Virus Therapies Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Virus Therapies Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Virus Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Virus Therapies Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Therapies Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Virus Therapies
Figure 19. Global Oncolytic Virus Therapies Market PEST Analysis
Figure 20. Global Oncolytic Virus Therapies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Virus Therapies Market Share by Type
Figure 27. Sales Market Share of Oncolytic Virus Therapies by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Virus Therapies by Type in 2025
Figure 29. Market Share of Oncolytic Virus Therapies by Type (2020-2025)
Figure 30. Market Share of Oncolytic Virus Therapies by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Virus Therapies Market Share by Application
Figure 33. Global Oncolytic Virus Therapies Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Virus Therapies Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Virus Therapies Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Virus Therapies Market Share by Application in 2025
Figure 37. Global Oncolytic Virus Therapies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Virus Therapies Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Virus Therapies Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Virus Therapies Market Size by Country in 2024
Figure 45. U.S. Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Virus Therapies Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Virus Therapies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Virus Therapies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Virus Therapies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Virus Therapies Market Size by Country in 2024
Figure 55. Germany Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncolytic Virus Therapies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Virus Therapies Market Size by Region in 2024
Figure 68. China Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 79. South America Oncolytic Virus Therapies Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Virus Therapies Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Virus Therapies Market Size by Country in 2024
Figure 82. Brazil Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Virus Therapies Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncolytic Virus Therapies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Virus Therapies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Virus Therapies Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Virus Therapies Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncolytic Virus Therapies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Virus Therapies Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncolytic Virus Therapies Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Virus Therapies Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncolytic Virus Therapies Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Virus Therapies Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Virus Therapies Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Virus Therapies Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Virus Therapies Market Share Forecast by Application (2026-2035)
